Kynurenine pathway metabolite levels are higher during gestation and decrease after birth. Environmental insults and genetic manipulations affect kynurenine pathway metabolism. Review of perinatal kynurenine pathway manipulations to study neuropathology and behavior of neurodevelopmental disorders. Interventions targeting KP enzymes or sites of action may constitute novel therapeutic strategies in psychiatric disorders.